Table 7 Summary of clinical trials of EVs in wound repair
Identifier | Condition or disease | Intervention/treatment | Phase |
|---|---|---|---|
NCT02565264 | Intractable cutaneous wound ulcer | Plasma-derived EVs | Early phase 1 |
NCT05078385 | Second degree burn wounds | BMSC-derived EVs | Phase 1 |
NCT04134676 | Chronic ulcer wounds | Stem cell-conditioned medium | Phase 1 |
NCT02138331 | Diabetes mellitus type 1 | MSC-derived EVs | Phase 2 Phase 3 |
NCT05243368 | Cutaneous ulcers in diabetics | MSC-derived EVs | Not applicable |
NCT04652531 | Ulcer venous | Autologous EVs from serum | Not applicable |
NCT05813379 | Skin rejuvenation (Anti-aging) | MSC-derived EVs | Phase 1 Phase 2 |
NCT05243368 | Diabetic foot | MSC-derived EVs | Not applicable |
NCT05475418 | Wounds and injuries | Adipose tissue derived exosomes | Not applicable |